CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Raphael Mechoulam

OPENALEX: A5065631892↗ORCID: 0000-0002-6122-5698↗

Affiliations

Organizations

Hadassah Medical Centerauthorship · IL Hebrew University of Jerusalemauthorship · IL Tel Aviv Universityauthorship · IL Weizmann Institute of Scienceauthorship · IL

Public evidence

4 connected articles

Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study.2022 · Europe PMC Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy.2019 · PubMed Central Open Access Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test.2018 · PubMed Central Open Access Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.2016 · Europe PMC

Registered research

Connected studies

Use of CBD Oil for Reducing the Negative Emotional Impact of COVID-19: A Randomized Placebo-Controlled Clinical Trialnct04603781

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Raphael Mechoulam - Medical Cannabis Research Engine